Valeant Pharmaceuticals International Inc. , a Canadian pharma focused on neurology and dermatology, made a hostile bid to buy Cephalon Inc. for about $5.7 billion, or $73 a share in cash.
How will this impact the CXS deal??
CXS Price at posting:
64.5¢ Sentiment: ST Sell Disclosure: Not Held
